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Recombinant Aplysiu rho and a GTP-binding protein purified from human neutrophil membranes (G& were ADP- 
ribosylated by botulinum toxin C, with stoichiometries of 0.8 and 0.6, respectively. Rho and G22K appeared to be different 
proteins since (i) rho migrated faster on polyacrylamide gels, (ii) unlike Gr2k, rho did not require the presence of cytosol 
to be ADP-ribosylated, (iii) GzK was not recognized by an anti-rho antiserum, and (iv) antibody 142-24E05 recognized 
G2rK effectively but only poorly cross reacted with rho. ADP-ribosylation had no effect on the ability of rho to bind or 
hydrolyse GTP. Therefore, it appears that there are multiple botulinum toxin C, substrates and that the toxin exerts 
its effects on cell function by a mechanism other than modulating the GTPase activity of rho. 
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1. INTRODUCTION 
A family of GTP-binding (G) proteins, with an 
crfly structure, serve as transducers for hormone 
receptors at the plasma membrane. This family in; 
eludes Gs and Gi, which regulate adenylate cyclase, 
G, and Gi proteins that appear to regulate 
phospholipases and ion channels, and the 
transducins which couple light-activated rhodopsin 
to retinal cGMP phosphodiesterase [1,2]. A 
characteristic of these proteins is that their cy- 
subunits are targets for bacterial toxin-catalysed 
ADP-ribosylation. Gs~ is ADP-ribosylated by 
cholera toxin, G& and Gia are ADP-ribosylated 
by pertussis toxin, and transducin a-subunits are 
targets for both toxins [1,2]. 
Another family of G-proteins exists that are 
monomers of approx. 21 kDa. These include the 
H-, K- and N-ras and the ras-related rho, ral, rab 
and rap gene products [3-71. It has recently been 
reported that the botulinurn toxin C3 (BTx C3), 
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produced by Ciostridium botulinurn types C and 
D, ADP-ribosylates proteins of 20-26 kDa [8,9]. 
We have previously demonstrated that a 22 kDa 
botulinurn toxin substrate (which we have termed 
G&, present in the tissues of species from several 
phyla, is a ras-related GTP-binding protein that is 
distinct from H-, K- and N-ras [ 10-121. 
Injection of the active subunit of BTx C3 into 
various cell types has been shown to induce 
changes in morphology and differentiation 
characteristic of p21-ras activation [13]. This sug- 
gests that the toxin activates process(es) regulated 
by ru,+gene products. Further, treatment of 
neutrophils and platelets with a preparation of 
botulinum toxin D, contaminated with BTx C3, 
resulted in potentiation of agonist-stimulated 
secretion 1141. Thus, ras-related BTx C3 substrates 
may be involved in membrane trafficking and/or 
secretion in addition to their effects on prolifera- 
tion and differentiation. It is anticipated that acute 
activation of rcls-related GTP-binding protein(s) 
by BTx C3-catalyzed ADP-ribosylation may pro- 
vide a better understanding of the role of these 
proteins in cell function, as well as of p21-ras in 
tumorigenesis. 
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We report here that bacterially expressed 
Apfysia rho is stoichiometrically ADP-ribosylated 
by BTx CS. This ADP-ribosylation produces no ef- 
fect on the guanine nucleotide binding capability 
or GTPase activity of the purified protein. 
Evidence is presented that rho is distinct from the 
neutrophil BTx CJ substrate, G22x. It seems likely 
that, analogous to pertussis toxin, there are multi- 
ple BTx C3 substrates in eukaryotic cells. 
2. MATERIALS AND METHODS 
2.1. ADP-ribosylation by botulinurn C3 toxin 
Samples (15 ~1 volume of protein f cytosol) were incubated 
in a total volume of 50 ~1 with final concentrations of 100 mM 
Tris-HCl, pH 8.0, 1 mM EDTA, 10 mM dithiothreitol, 1 mM 
ATP, 0.5 mM L-cy-dimyristoylphosphatidylcholine, 10 mM 
thymidine, 2.5 mM MgCls, 2 or 4 mM NAD (5000-20000 
cpm/pmol) and 0.5 gg/ml botulinum Cs toxin. Incubations 
were for 120 min at 30°C, and were terminated by addition of 
Laemmli sample buffer [IS]. For estimation of stoichiometry, 
incubations were terminated by addition of 1 ml of 1.0% SDS, 
100 &ml bovine serum albumin, and 15% trichloroacetic 
acid. Precipitated proteins were vacuum filtered over BASS 
nitrocellulose filters and washed 5 times with 2 ml of 6% 
trichloroacetic acid, then counted by liquid scintillography. 
Neutrophil cytosol was passed over a Sephadex G25 column to 
separate proteins from endogenous NAD. 
2.2. Immunoblotting 
Western blots were performed essentially as described by 
Towbin [la]. Anti-rus monoclonal antibodies Y13-259 [3] and 
142-24E05 [17] were obtained from Oncogene Science, Inc., 
and the National Cancer Institute Repository, Microbiological 
Associates, respectively. Anti-rho antibody was prepared 
against he intact bacterially expressed rho, as described in [ 181. 
2.3. Proteins 
Bacterially expressed H-ras was a generous gift from Chan- 
ning Der, La Jolla Cancer Research Foundation, La Jolla, CA. 
Rho was expressed and purified as in [18]. GZK was purified as 
described in [12]. Botulinum Cp toxin and anti-C3 toxin an- 
tibody were prepared as previously described [19,20]. 
2.4. GTPyS binding/GTPase assay 
Binding of [‘sS]GTPyS was essentially as described in [21]. 
For estimation of GTP hydrolytic activity, rho was incubated 
for 60 min in the presence or absence of BTx Cr under standard 
ADP-ribosylation conditions. 20 ,ul of the ribosylation reaction 
(10 pmol GTP-binding protein) was then incubated at 30°C for 
the indicated times in a reaction mix (50 $1 final volume) con- 
taining 25 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM 
dithiothreitol, 150 mM NaCl, 3 mM Lir-dimyristoylphosphati- 
dylcholine, 5 mM MgCl2, and 1 pM GTP (1.5 x 10’ cpm/ 
tube). Reactions were terminated by the addition of 750~1 of 
ice-cold charcoal (5%, w/v) in 20 mM phosphoric acid. Tubes 
were kept on ice for 10 min prior to centrifugation (1 min, 
Beckman Microfuge E) at room temperature. The amount of 
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“Pi released was then determined by counting a 0.5 ml aliquot 
of the clear supernatant. 
2.5. Miscellaneous 
Gels were run according to Laemmli [15] and were 15% 
polyacrylamide. Silver staining was as described [22]. Protein 
values were obtained by amido black assay [23]. All chemicals 
were of the highest grade available. The GTPase data have been 
presented in terms of pmol GTPyS binding, which is a measure 
of active G-protein. The stoichiometry of ADP-ribosylation of 
Gi by pertussis toxin was shown to correlate with the extent of 
guanine nucleotide binding by the protein [29] and denatured 
rho (lOO’C, 3 min or repeated freeze thawing) did not serve as 
a substrate for BTx Cs. These findings suggest hat normaliza- 
tion to GTPyS binding is also valid for ADP-ribosylation. 
There were 0.2 and 0.5 pmol GTPyS bound/pm01 rho and 
Gszx, respectively. 
3. RESULTS 
The Aplysia rho protein, purified from a 
bacterial expression system [ 181, is shown in fig. 1, 
lane 2. The expressed protein has an apparent 
molecular mass of 20500 Da, similar to that 
reported for rho purified from bovine brain [24] 
and consistent with the molecular mass predicted 
by the cloned Aplysia gene [4]. Bacterially ex- 
pressed H-ras (lane 1) and two separate prepara- 
tions of human neutrophil &K protein (lanes 3,4) 
are shown for comparison. Both of these proteins 
migrate slower than rho on SDS-polyacrylamide 
gels, with apparent molecular masses of 22-23 
kDa. 
3.1. ADP-ribosylation of rho by botulinum C3 
toxin 
We examined the ability of each of these ras- 
related proteins to serve as substrates for ADP- 
ribosylation by BTx CS toxin. GZK, as previously 
reported [12], was able to serve as a BTx C3 
substrate in the presence but not in the absence of 
neutrophil cytosol (fig.2, lanes 6,7). Under these 
same conditions, bacterially expressed Aplysia rho 
protein (lane 4) was also ADP-ribosylated in the 
presence of toxin. Labeling of rho by BTx C3 toxin 
was not dependent upon cytosolic factor, but the 
extent of ADP-ribosylation was somewhat en- 
hanced in the presence of cytosol (lane 5). As 
presented in table 1, the enhancement of labeling 
by cytosol was typically much less than that shown 
in fig.2. In contrast to GZZK and rho, bacterially ex- 
pressed H-ras did not serve as a toxin substrate, 
either in the presence or absence of cytosol (lanes 
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Fig.1. Silver stain visualization of low molecular mass GTP- 
binding proteins. Lanes: 1, 100 ng H-ras; 2, 100 ng rho; 3, 
200 ng GZZK (Prep 1); 4, 100 ng GZZK (Prep 2). 
2,3). We have also determined that other low 
molecular mass GTP-binding proteins, including 
bovine ARF [25] and GNK or C&K from human 
neutrophils [l 1,121, do not serve as BTx C3 toxin 
substrates (not shown). The labeling of both rho 
and G22~ by BTx CS is specific for that component, 
as evidenced by the ability of an anti-C3 toxin an- 
tibody to inhibit ADP-ribosylation of both pro- 
teins (fig.2, lanes 9-12). 
The stoichiometry of the ADP-ribosylation of 
rho and GZZK by BTx CS was assessed, these data 
being shown in table 1. We were able to ADP- 
ribosylate rho to an extent of approx. 0.8 mol/mol 
of GTPyS binding both in the absence and 
presence of neutrophil cytosol. There thus appears 
to be a single site for ADP-ribosylation on rho. 
Ribosylation of GZZK to a level of 0.63 mol/mol of 
GTPyS binding was only achieved in the presence 
of neutrophil cytosol. In contrast, H-ras was not 
significantly ADP-ribosylated: values of less than 
0.06 mol/mol of GTPyS binding were obtained. 
3.2. Immunological distinction between GZZK and 
rho 
In order to assess possible relationships between 
the neutrophil botulinum toxin substrate, G~zK, 
Fig.2. ADP-ribosylation of low molecular mass GTP-binding 
proteins by botulinum Cs toxin. Samples were ADP-ribosylated 
in the presence of [“PINAD as described in section 2. Lanes: 
1, cytosol alone; 2, 60 ng H-ras; 3, 60 ng H-ras + cytosol; 4, 
30 ng rho; 5, 30 ng rho + cytosol; 6, 60 ng GZZK; 7, 60 ng 
Gsrx + cytosol; 8, protein blank (toxin alone); 9,60 ng GZZK + 
cytosol; 10, 60 ng GZZK + cytosol + 1: 200 dilution of anti-C, 
antibody; 11, 30 ng rho; 12, 30 ng rho + 1: 200 dilution of anti- 
Cs antibody. (Note: lanes 9-12 are from a separate xperiment 
than lanes l-8). 
and rho, we examined the ability of several an- 
tibodies to cross-react with these proteins. A 
polyclonal antibody prepared against he bacterial- 
ly expressed Aplysia rho protein clearly recognized 
rho, but not H-ras or GZZK (fig.3, lanes l-3). In 
contrast, monoclonal antibody 142-24EO5 recog- 
nized both G22~ and H-ras effectively, but only 
poorly cross-reacted with an equivalent amount of 
rho protein (fig.3, lanes 4-6). Monoclonal an- 
tibody Y13-259 only detected H-ras (fig.3, lanes 
Table 1 
Stoichiometry of ADP-ribosylation by botulinum toxin Cs 
Protein Cytosol ADP-ribose incorporated/ 
GTPyS-binding site (mol/mol)a 
&K 
Rho 
H-ras 
- 0.03 (0.03, 0.04) 
+ 0.60 (0.66, 0.53) 
- 0.73 (0.60, 0.86) 
+ 0.82 (0.76, 0.87) 
- 0.02 (0.02, 0.02) 
+ 0.06 (0.08, 0.04) 
a Values are averages of two separate experiments, with 
samples assayed in duplicate. Values determined from each 
experiment are shown in parentheses. Buffer and cytosol 
blanks were subtracted in order to estimate incorporation into 
the proteins of interest 
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Fig.3. Recognition of GZZK, rho, and H-rus by various 
antibodies. (Lanes 1,4,7) 100 ng H-rus; (lanes 2,5,8) 100 ng 
rho; (lanes 3,6,9) 100 ng G22x. Anti-rho antibody was used at 
1:200 dilution, 142~24EOS at 1:500 dilution, and Yl3-259 at 
1: 250 dilution. Blotting was performed as described in section 
2. Molecular mass markers are indicated at the right of the 
figure. 
7-9). These proteins therefore appear to be im- 
munologically distinct from each other. This is 
consistent with partial amino acid sequence infor- 
mation we have previously obtained from GZZK 
Pa 
3.3. Effect of ADP-ribosylation of rho on guanine 
nucleotide binding and hydrolysis 
We examined the effect of ADP-ribosylation of 
rho by BTx C3 on the ability of rho to bind 
[35S]GTPyS. The extent of binding was not signifi- 
cantly modified by ribosylation. An equilibrium 
value of 580 pmol/ml was obtained for non-ribo- 
sylated rho as compared to 520 pmol/ml (average 
of duplicate determinations, n = 2 experiments) 
for protein ribosylated to an extent of 
0.86 mol/mol. The rate of [3SS]GTPyS binding to 
the ADP-ribosylated rho was not significantly dif- 
ferent from that of the non-ribosylated protein 
(not shown). The rate of hydrolysis of GTP by rho 
was approx. 0.5 pmol/pmol GTPyS binding per 
min. This activity was not altered by prior ADP- 
ribosylation of rho (fig.4). 
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Fig.4. Time course of GTP hydrolysis by control and ADP- 
ribosylated rho. The GTPase activity of 10 pmol rho protein 
was determined following incubation in the presence (0) and 
absence (0) of BTx Cs as indicated in section 2. The results 
shown are the mean of triplicate samples and are representative 
of three independent experiments. Standard deviations were less 
than 5%. 
4. DISCUSSION 
We have used a bacterially expressed Aplysia 
rho protein to investigate the possibility that rho is 
a substrate for BTx C3 and to compare the proper- 
ties of this GTP-binding protein with those of 
G~zK, purified from human neutrophils. Aplysia 
rho was indeed ADP-ribosylated by BTx C3 with a 
stoichiometry close to unity, suggesting that there 
is a single site for ribosylation on the protein. The 
difference in mobility of rho and GZZK on 
polyacrylamide gels and the lack of an absolute re- 
quirement for cytosol to ADP-ribosylate rho sug- 
gested that GZK and rho were distinct proteins. An 
additional indication that the neutrophil G22x 
botulinum toxin substrate and rho are not the same 
protein comes from the observation that rho was 
not as immunoreactive as GZZK or H-ras with the 
142-24E05 antibody and GZZK was not recognized 
by the anti-rho polyclonal antiserum. This lack of 
recognition by the anti-rho antibody seems unlike- 
ly to result from species differences in rho, as the 
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antibody was prepared against the whole Aplysia 
rho protein, which has an overall homology of 
-85% with the human forms of rho [4], although 
we cannot rule out this possibility. 
Injection of BTx C3 into several cell types has 
been reported to cause effects similar to the in- 
troduction of activated (oncogenic) forms of ras. 
Activated forms of ras exist in the GTP bound 
state and frequently possess a decreased ability to 
hydrolyze GTP [3]. ADP-ribosylation of G,cu by 
cholera toxin results in inhibition of its intrinsic 
GTPase activity, maintaining the protein in a state 
able to cause persistent activation of adenylate 
cyclase [ 11. However, near stoichiometric ADP- 
ribosylation of rho did not affect its GTP-binding 
or GTPase activity. Other mechanisms therefore 
need to be considered for botulinum C3 toxin- 
mediated effects on cell function. It is possible that 
the interaction of rho with some effector 
molecule(s) might be modified by ADP- 
ribosylation, without inhibition of its intrinsic 
GTPase activity. Some transforming mutants of 
p21 ras have similar GTPase activity to normal r-as 
in vitro but still cause cellular transformation [26]. 
However, it has recently been found that the 
GTPase activities of these mutants is much lower 
in vivo than normal p21 because they are resistant 
to stimulation by the GTPase-activating protein, 
GAP, the putative effector of ras [27]. ADP- 
ribosylation of rho might similarly affect its in- 
teraction with a GAP-like regulator of its GTPase 
activity in vivo. 
During the preparation of this manuscript, it 
was reported by Kikuchi et al. [28] that rho pro- 
tein, purified from bovine brain, also served as a 
substrate for a botulinum toxin. Our data have 
confirmed their finding that ADP-ribosylation 
does not attenuate the GTPase activity of bovine 
rho. Kikuchi et al. used a preparation of 
botulinum toxin Cr, presumably contaminated 
with the Cs component that is expressed by the C 
and D strains of Clostridium botulinum. We dem- 
onstrate here that the CS toxin is responsible for 
ADP-ribosylation of both rho and G22k by using a 
purified toxin preparation and a C3-specific an- 
tiserum. 
Thus, rho protein is a substrate for BTx C3 but 
there are additional substrates present in human 
neutrophils (GzK), and possibly in other tissues. 
There are at least three human rho genes [4], the 
products of which could each be BTx CJ 
substrates. In addition, an amino acid sequence 
homologous to rapl [7] has been obtained from a 
preparation of GZ~K [12], SUggeSting that it may 
also be ADP-ribosylated by botulinum toxin. This 
situation is analogous to pertussis toxin, which 
ADP-ribosylates the three Gi proteins as well as Go 
and transducin. The total number and identity of 
BTx C3 substrates remains to be determined. 
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